You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dulaglutide

Showing 1 - 25 of 54
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial (Dulaglutide)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Dulaglutide
  • (no location specified)
Dec 20, 2022

Healthy Volunteers, Diabetes, Type 2, Overweight Trial in Groningen (Semaglutide, Dulaglutide)

Completed
Has Results
  • Healthy Volunteers
  • +3 more
  • Groningen, Netherlands
    Novo Nordisk Investigational Site
Nov 4, 2022

Metabolic-associated Fatty Liver Disease, Type 2 Diabetes Trial (Empagliflozin, Dulaglutide, Empagliflozin and Dulaglutide)

Not yet recruiting
  • Metabolic-associated Fatty Liver Disease
  • Type 2 Diabetes
  • (no location specified)
Oct 1, 2022

T2DM (Type 2 Diabetes) Trial in Shanghai (Ecnoglutide high dosage, Ecnoglutide low dosage, Dulaglutide)

Not yet recruiting
  • T2DM (Type 2 Diabetes Mellitus)
  • Ecnoglutide high dosage
  • +3 more
  • Shanghai, Shanghai, China
    ZHONGSHAN Hospital
Dec 25, 2022

Novel Antidiabetic Medications and Their Effect on Liver

Completed
  • Non-Alcoholic Fatty Liver Disease
  • Liver Steatosis
  • Athens, Attiki, Greece
    "Hippocration" General Hospital of Athens
Jul 13, 2023

Type 2 Diabetes Trial in Beijing (dulaglutide, IBI362)

Not yet recruiting
  • Type 2 Diabetes
  • Beijing, China
    China-Japan Friendship Hospital
Nov 1, 2022

Type 2 Diabetes, Glucose, High Blood Trial in Cheonju (IGlarLixi, Dulaglutide)

Active, not recruiting
  • Type 2 Diabetes Mellitus
  • Glucose, High Blood
  • Cheonju, Chungcheongbuk-do, Korea, Republic of
    Chungbuk National University Hospital
Jul 19, 2022

Type 2 Diabetes Treated With Insulin, Obesity, Adolescent Obesity Trial in Lahore (Dulaglutide, Liraglutide)

Completed
  • Type 2 Diabetes Treated With Insulin
  • +2 more
  • Lahore, Punjab, Pakistan
    Zainab Khan
Mar 11, 2022

Diabetes, Type 2 Trial in United States (LY3457263, Placebo, Dulaglutide)

Recruiting
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +4 more
Dec 8, 2022

Type 2 Diabetes Trial in Beijing (IBI362, , Dulaglutide)

Active, not recruiting
  • Type 2 Diabetes
  • Beijing, Beijing, China
    China Japan Friendship Hospital
Jul 15, 2022

Hyperglycemia Stress Trial in Atlanta (Dulaglutide, Placebo, Continuous glucose monitor (CGM), blinded)

Recruiting
  • Hyperglycemia Stress
  • Dulaglutide
  • +2 more
  • Atlanta, Georgia
  • +1 more
Dec 6, 2022

Sexual Functioning Trial in Basel (Dulaglutide, Placebo)

Recruiting
  • Sexual Functioning
  • Dulaglutide
  • Placebo
  • Basel, Switzerland
    University Hospital Basel, Endocrinology, Diabetes and Metabolis
Mar 3, 2022

Diabetes, Diabetic Kidney Disease Trial in Sha Tin (Dulaglutide, Insulin Degludec, Continuous glucose monitor)

Recruiting
  • Diabetes Mellitus
  • Diabetic Kidney Disease
  • Dulaglutide
  • +2 more
  • Sha Tin, Hong Kong
    Prince of Wales Hospital
Nov 8, 2022

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Dulaglutide)

Recruiting
  • Type 2 Diabetes
  • Cooper City, Florida
  • +43 more
Jan 17, 2023

Diabetes, Type 2, Overweight or Obesity Trial in China (Beinaglutide, Dulaglutide)

Recruiting
  • Diabetes Mellitus, Type 2
  • Overweight or Obesity
  • Guangzhou, Guangdong, China
  • +3 more
Aug 25, 2021

Diabetes, Type 1, Endothelial Dysfunction Trial in Charlottesville (Dulaglutide, Placebo, exercise training)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Endothelial Dysfunction
  • Dulaglutide
  • +2 more
  • Charlottesville, Virginia
    University of Virginia
Jul 25, 2022

Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial in Japan (Dulaglutide, Biguanide (BG), Sulfonylurea (SU))

Active, not recruiting
  • Diabetes Mellitus
  • +6 more
  • Dulaglutide
  • +6 more
  • Nagoya-shi, Aichi, Japan
  • +43 more
Jan 16, 2023

Diabetes, Type 2 Trial in Anaheim, Miami, San Antonio (LY3493269, Dulaglutide, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Anaheim, California
  • +2 more
Apr 4, 2022

Type 2 Diabetes Trial in China (Dulaglutide, Placebo, Insulin Glargine)

Completed
  • Type 2 Diabetes Mellitus
  • Dulaglutide
  • +2 more
  • Hefei, Anhui, China
  • +26 more
May 16, 2022

Diabetes, Type 2 Trial in Neuss (LY3532226, Placebo, Dulaglutide)

Recruiting
  • Diabetes Mellitus, Type 2
  • Neuss, Germany
    Profil Institut für Stoffwechselforschung
Jun 30, 2022

Adult Subjects With Type1Diabetes and Insulin Microsecretion Trial in France (Dulaglutide, Placebo)

Completed
  • Adult Subjects With Type1Diabetes and Insulin Microsecretion
  • Dulaglutide
  • Placebo
  • La Tronche, France
  • +6 more
Jul 7, 2021

Healthy, Type 2 Diabetes Trial in Neuss, Mainz (LY3457263, Dulaglutide, Placebo)

Completed
  • Healthy
  • Type 2 Diabetes
  • Neuss, Nordrhein-Westfalen, Germany
  • +1 more
Jan 10, 2022

Type 2 Diabetes Trial in Worldwide (Dulaglutide, Placebo)

Completed
Has Results
  • Type 2 Diabetes
  • Dulaglutide
  • Placebo
  • Birmingham, Alabama
  • +60 more
Jun 7, 2022

Type 2 Diabetes Trial in Worldwide (Efpeglenatide, Dulaglutide, Background therapy Metformin)

Terminated
Has Results
  • Type 2 Diabetes Mellitus
  • Birmingham, Alabama
  • +44 more
Oct 28, 2021

Type 2 Diabetes Trial in Beijing (IBI362, Placebo, Dulaglutide)

Completed
  • Type 2 Diabetes
  • Beijing, China
    China Japan Friendship Hospital
Jul 21, 2021